NKGen Biotech, Inc.
NKGNDelisted Jul 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001845459
NKGen Biotech, Inc. was delisted on Jul 17, 2025; its insiders filed their last Form 4 on Jun 2, 2025; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding NKGen Biotech, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 13 | 17 | +4 |
| Shares | 3.02M | 3.42M | +398.0K (+13.2%) |
| Value | $5.66M | $4.24M | −$1.42M (−25.1%) |
New holders (6)
Institutions that held NKGen Biotech, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Diametric Capital, LP | 333,334 | $423.3K | 0.23% |
| Virtu Financial LLC | 18,917 | $24.0K | 0.00% |
| BlackRock Inc. | 16,966 | $21.5K | 0.00% |
| State Street Corp | 11,200 | $14.2K | 0.00% |
| HRT Financial LP | 11,389 | $14.0K | 0.00% |
| Bank of America Corp | 50 | $64 | 0.00% |
Sold out (2)
Institutions that held NKGen Biotech, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 16,906 | $32.0K |
| Wells Fargo & Company | 48 | $91 |